Klaria Pharma Holding AB (KLAR) — Capital Reinvestment Ratio

Latest as of March 2020: 0.07x

Klaria Pharma Holding AB (KLAR) has a Capital Reinvestment Ratio of 0.07x as of March 2020, meaning it reinvests 0% of its operating cash flow (Skr442.00K) in capital expenditures (Skr33.00K). See KLAR equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

Skr442.00K
SEK

Capital Expenditures

Skr33.00K
SEK

Data as of

Mar 2020
Most recent filing

Annual Capital Reinvestment Ratio for Klaria Pharma Holding AB (None–None)

Year-by-year Capital Reinvestment Ratio for Klaria Pharma Holding AB from None to None. For live market cap and broader valuation context, see KLAR stock market capitalisation.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow